MRI-guided percutaneous thermoablation as first-line treatment of recurrent hepatic malignancies following hepatic resection: single center long-term experience

References

• Kanwal F, Singal AG. Surveillance for hepatocellular carcinoma: current best practice and future direction. Gastroenterology. 2019;157(1):54–64.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386–1422.
   PubMed Web of Science ®Google Scholar
• Frilling A, Clift AK. Surgical approaches to the management of neuroendocrine liver metastases. Endocrinol Metab Clin North Am. 2018;47(3):627–643.
   PubMed Web of Science ®Google Scholar
• Bacalbasa N, Balescu I, Ilie V, et al. The impact on the long-term outcomes of hormonal status after hepatic resection for breast cancer liver metastases. In Vivo. 2018;32(5):1247–1253.
   PubMed Web of Science ®Google Scholar
• de Jong MC, Pulitano C, Ribero D, et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg. 2009;250(3):440–448.
   PubMed Web of Science ®Google Scholar
• Dupre A, Jones RP, Diaz-Nieto R, et al. Curative-intent treatment of recurrent colorectal liver metastases: a comparison between ablation and resection. Eur J Surg Oncol. 2017;43(10):1901–1907.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–338.
   PubMed Web of Science ®Google Scholar
• Elias D, De Baere T, Smayra T, et al. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg. 2002;89(6):752–756.
   PubMed Web of Science ®Google Scholar
• ten Broek RP, Issa Y, van Santbrink EJ, et al. Burden of adhesions in abdominal and pelvic surgery: systematic review and met-analysis. BMJ. 2013;347:f5588.
   PubMed Web of Science ®Google Scholar
• Schullian P, Johnston EW, Putzer D, et al. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection. Eur J Surg Oncol. 2021;47(4):866–873.
   PubMed Web of Science ®Google Scholar
• Schullian P, Laimer G, Putzer D, et al. Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection. Eur J Surg Oncol. 2020;46(8):1503–1509.
   PubMed Web of Science ®Google Scholar
• Mao R, Zhao JJ, Bi XY, et al. Resectable recurrent colorectal liver metastasis: can radiofrequency ablation replace repeated metastasectomy? ANZ J Surg. 2019;89(7-8):908–913.
   PubMed Web of Science ®Google Scholar
• Maurer MH, Schreiter N, de Bucourt M, et al. Cost comparison of nerve root infiltration of the lumbar spine under MRI and CT guidance. Eur Radiol. 2013;23(6):1487–1494.
   PubMed Web of Science ®Google Scholar
• Wijlemans JW, Bartels LW, Deckers R, et al. Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) ablation of liver tumours. Cancer Imaging. 2012;12(2):387–394.
   PubMed Web of Science ®Google Scholar
• Fischbach F, Lohfink K, Gaffke G, et al. Magnetic resonance-guided freehand radiofrequency ablation of malignant liver lesions: a new simplified and time-efficient approach using an interactive open magnetic resonance scan platform and hepatocyte-specific contrast agent. Invest Radiol. 2013;48(6):422–428.
   PubMed Web of Science ®Google Scholar
• Salem U, Kumar VA, Madewell JE, et al. Neurosurgical applications of MRI guided laser interstitial thermal therapy (LITT). Cancer Imaging. 2019;19(1):65.
   PubMed Web of Science ®Google Scholar
• Rempp H, Waibel L, Hoffmann R, et al. MR-guided radiofrequency ablation using a wide-bore 1.5-T MR system: clinical results of 213 treated liver lesions. Eur Radiol. 2012;22(9):1972–1982.
   PubMed Web of Science ®Google Scholar
• Rempp H, Unterberg J, Hoffmann R, et al. Therapy monitoring of magnetic resonance-guided radiofrequency ablation using T1- and T2-weighted sequences at 1.5 T: reliability of estimated ablation zones. Invest Radiol. 2013;48(6):429–436.
   PubMed Web of Science ®Google Scholar
• Filippiadis DK, Binkert C, Pellerin O, et al. Cirse quality assurance document and standards for classification of complications: the Cirse classification system. Cardiovasc Intervent Radiol. 2017;40(8):1141–1146.
   PubMed Web of Science ®Google Scholar
• Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–196.
   PubMed Web of Science ®Google Scholar
• Kierans AS, Elazzazi M, Braga L, et al. Thermoablative treatments for malignant liver lesions: 10-year experience of MRI appearances of treatment response. Am J Roentgenol. 2010;194(2):523–529.
   PubMed Web of Science ®Google Scholar
• Weiss J, Winkelmann MT, Gohla G, et al. MR-guided microwave ablation in hepatic malignancies: clinical experiences from 50 procedures. Int J Hyperthermia. 2020;37(1):349–355.
   PubMed Web of Science ®Google Scholar
• Lintoiu-Ursut B, Tulin A, Constantinoiu S. Recurrence after hepatic resection in colorectal cancer liver metastasis. J Med Life. 2015;8(Spec Issue):12–14.
   PubMedGoogle Scholar
• Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241(5):715–722; discussion 22–24.
   PubMed Web of Science ®Google Scholar
• Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239(6):818–825; discussion 25–27.
   PubMed Web of Science ®Google Scholar
• Sofocleous CT, Petre EN, Gonen M, et al. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J Vasc Interv Radiol. 2011;22(6):755–761.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhao J, Gu HAO, et al. Repeat hepatic resection VS radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma: an updated meta-analysis. Minim Invasive Ther Allied Technol. 2020:1–10.
   Web of Science ®Google Scholar
• Clasen S, Pereira PL. Magnetic resonance guidance for radiofrequency ablation of liver tumors. J Magn Reson Imaging. 2008;27(2):421–433.
   PubMed Web of Science ®Google Scholar
• Chiou SY, Liu JB, Needleman L. Current status of sonographically guided radiofrequency ablation techniques. J Ultrasound Med. 2007;26(4):487–499.
   PubMed Web of Science ®Google Scholar
• Maegerlein C, Fingerle AA, Souvatzoglou M, et al. Detection of liver metastases in patients with adenocarcinomas of the gastrointestinal tract: comparison of (18)F-FDG PET/CT and MR imaging. Abdom Imaging. 2015;40(5):1213–1222.
   PubMedGoogle Scholar
• Schullian P, Johnston E, Laimer G, et al. Thermal ablation of CT ‘invisible’ liver tumors using MRI fusion: a case control study. Int J Hyperthermia. 2020;37(1):564–572.
   PubMed Web of Science ®Google Scholar
• Bo XW, Xu HX, Wang D, Guo LH, et al. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers. Br J Radiol. 2016;89(1067):20160379.
   PubMed Web of Science ®Google Scholar
• Baran B, Mert Ozupek N, Yerli Tetik N, et al. Difference between left-sided and right-sided colorectal cancer: a focused review of literature. Gastroenterology Res. 2018;11(4):264–273.
   PubMed Web of Science ®Google Scholar
• Yahagi M, Okabayashi K, Hasegawa H, et al. The worse prognosis of right-sided compared with left-sided colon cancers: a systematic review and meta-analysis. J Gastrointest Surg. 2016;20(3):648–655.
   PubMed Web of Science ®Google Scholar